More Galleries
Rebirth of America's dead factories Defunct factories around the country are in high demand as U.S. production once again revs up. More
7 hot businesses to start now It's hard to predict what businesses will take off, but these startup ideas have been drawing tons of interest from entrepreneurs and their customers on Thumbtack.com. More
How will a minimum wage hike hit businesses? Thirteen states increased the minimum wage on Jan. 1, and President Obama supports raising the federal rate to $10.10. 4 small business owners weigh in on how an increase would affect them. More

Special Offer
32 of 36
BACK NEXT
Better breast cancer screening
Better breast cancer screening
Phil Smith, H. Lee Mosbacker and Michael Hetzer
Team name: Traycer Diagnotic Systems

School: Ohio State University, Fisher College of Business

Team members: Bradley G. Beasecker, H. Lee Mosbacker, Michael Hetzer, Arthur J. Epstein, John D. Bair, Phil Smith, Matt Carbonara

Concept: According to the American Cancer Society, one in eight American women will be diagnosed with breast cancer at some point in their lives. More than 35 million mammograms were performed in the U.S. last year. Headed by scientists and venture capitalists, Traycer Diagnostic Systems (TDS) promises less invasive, less painful breast cancer screening and diagnosis based on imaging technologies that can identify cancer cells based on their chemical signatures.

Using patented technologies developed at Ohio State University, TDS hopes to create diagnostic imaging machines that can scan and detect breast tumors more accurately and cheaply than current analog and digital mammography systems. In theory this should reduce the need for costly and invasive biopsies.

Timeline: TDS hopes to have a product on the market in about three years, allowing reasonable time for R&D and FDA approval. - Jennifer Lawinski

NEXT: Counterfeiters beware

Last updated May 02 2008: 11:51 AM ET
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.